Global healthcare company, Abbott, announced that its continuous glucose monitoring system Lingo can now be purchased in the U.S. without a prescription. Lingo contains a biosensor and mobile app that ...

The CGM market presents significant opportunities driven by rising diabetes prevalence and technological advancements. Key ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...

Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient ...

STATEN ISLAND, N.Y. — Abbott is asking consumers to be cautious when using glucose monitoring systems, due to a potential fire hazard, according to a notice by the U.S. Food and Drug Administration ...

Blood glucose monitoring systems (BGMS) have become an integral component in the management of diabetes, providing patients and clinicians with essential real‐time information to guide treatment ...

Clinicians who provide care for persons with diabetes are excited about continuous glucose monitoring (CGM). The technology with CGM is evolving and becoming more reliable and affordable; as it does, ...

TEL AVIV, Israel--(BUSINESS WIRE)--HAGAR, the developer of GWave, a revolutionary non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in the blood, ...

SINGAPORE--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM ...

Cambridge, UK – 21 October 2025 - TTP’s Biosensing team has demonstrated how a system-level design approach can overcome one ...